Information Provided By:
Fly News Breaks for November 30, 2018
UNH, DGX, LH
Nov 30, 2018 | 09:51 EDT
LabCorp (LH) this morning followed Quest Diagnostics' (DGX) lead and lowered its guidance due to lower volumes in the Diagnostics business, Piper Jaffray analyst William Quirk tells investors in a research note. The analyst, however, believes the volume softness is "largely short-term" when excluding UnitedHealth (UNH) and provides a long-term buying opportunity. He keeps an Overweight rating on LabCorp but lowered his price target for the shares to $177 from $180 to "reflect this setback."
News For LH;DGX;UNH From the Last 2 Days
UNH
Apr 19, 2024 | 04:50 EDT
Deutsche Bank analyst George Hill raised the firm's price target on UnitedHealth to $562 from $545 and keeps a Buy rating on the shares. The company reported a Q1 earnings beat with many moving pieces caused by the cyberattack on Change Healthcare, which left earnings quality and guidance up to investor interpretation, the analyst tells investors in a research note. The firm sees the full impact of the hack, as well as conservatism around cost trend and utilization would impact UnitedHealth earnings by only 2% for the full year.
UNH
Apr 18, 2024 | 09:56 EDT
Notable gainers among liquid option names this morning include Genuine Parts (GPC) $159.09 +15.03, Globe Life (GL) $66.97 +3.74, Anthem (ELV) $532.10 +23.13, United Continental (UAL) $50.59 +1.84, and UnitedHealth (UNH) $494.80 +15.81.
UNH
Apr 18, 2024 | 09:41 EDT
Unusual total active option classes on open include: Wrap Technologies (WRAP), AstraZeneca (AZN), JetBlue (JBLU), United Continental (UAL), Taiwan Semi (TSM), Nokia (NOK), EBay (EBAY), Maplebear Inc (CART), Airbnb (ABNB), and UnitedHealth (UNH).
UNH
Apr 17, 2024 | 08:11 EDT
RBC Capital analyst Ben Hendrix lowered the firm's price target on UnitedHealth to $555 from $596 but keeps an Outperform rating on the shares. The company reported a "better than feared" Q1, but the debate over utilization trends is expected to persist through the first half as excess reserves skew the medical care ratio picture, the analyst tells investors in a research note. RBC also notes that its added caution reflects UnitedHealth's "reduced claims visibility".